SEC
BHVN icon

Seven Eight Capital’s Biohaven BHVN Stock Holding History

Seven Eight Capital’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-54,863
Closed -$2.74M – 77
2024
Q3 		$2.74M Buy
54,863
+16,139
+42% +$628K 0.25% 109
2024
Q2 		$1.34M Buy
+38,724
New +$1.53M 0.14% 249
2024
Q1 		– Sell
-13,110
Closed -$561K – 617
2023
Q4 		$561K Buy
+13,110
New +$408K 0.06% 399
2023
Q3 		– Sell
-29,443
Closed -$704K – 597
2023
Q2 		$704K Buy
+29,443
New +$507K 0.12% 240

Other funds holding BHVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Seven Eight Capital's BHVN Position: Q4 2024 in Review

Seven Eight Capital sold out of Biohaven (BHVN) in Q4 2024, closing a stake of 54,863 shares — an estimated $2.74M sold.

Seven Eight Capital first reported a position in BHVN in Q2 2023 and held it in 4 quarters. The position peaked at $2.74M in Q3 2024. 256 funds tracked by Wall St. Rank hold BHVN as of Q4 2024.

  • Seven Eight Capital reported no remaining Biohaven position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 54,863 Biohaven shares in Q4 2024, an estimated $2.74M.
  • Seven Eight Capital first reported a position in Biohaven in Q2 2023 and held it in 4 quarters.
  • Seven Eight Capital's Biohaven position peaked at $2.74M in Q3 2024.
  • 256 funds tracked by Wall St. Rank held Biohaven as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.